首页> 外文期刊>Clinical Medicine Insights: Pathology >Bilateral Basal Cell Adenocarcinoma of the Parotid Gland: In a Recipient of Kidney Transplant
【24h】

Bilateral Basal Cell Adenocarcinoma of the Parotid Gland: In a Recipient of Kidney Transplant

机译:腮腺的双侧基底细胞腺癌:在肾脏移植的收件人。

获取原文
       

摘要

We report a rare case of bilateral basal cell adenocarcinoma (BcAC) of the parotid gland in a male patient 30 years after kidney transplantation and continuous administration of immunosuppressive therapy. BcAC is a salivary gland malignancy first recognized as a distinct neoplastic entity in WHO classification of salivary gland tumours in 1991. Over 90% of BcACs are detected in the parotid gland. The most important differential diagnosis is basal cell adenoma. Infiltrative growth is the distinguishing feature of BcAC. Administration of immunosuppressive medication to this patient for three decades may have contributed to development of this rare neoplasia. To our knowledge, similar cases of BcAC have not been reported previously.
机译:我们报道了在肾脏移植和免疫抑制治疗连续给药30年后的男性患者中腮腺的双侧基底细胞腺癌(BcAC)的罕见病例。 BcAC是涎腺恶性肿瘤,1991年在WHO唾液腺肿瘤分类中首次被公认是独特的赘生物。在腮腺中检测到90%以上的BcAC。最重要的鉴别诊断是基底细胞腺瘤。浸润性生长是BcAC的显着特征。对该患者进行免疫抑制药物治疗三十年,可能有助于这种罕见的肿瘤形成。据我们所知,以前尚未报道过类似的BcAC病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号